Due to pathogenic variants in VHL (on chromosome 3p25.3), VHL syndrome is due to loss of function of this tumor suppressor gene that encodes for an E3 ubiquitin ligase that targets HIF-2α for degradation (53). Here, EPAS1 is linked to neoplasm.